The Evolution Engine
AI-guided directed evolution meets modular bioconjugation. Evolve peptides that perform, then assemble them into next-generation therapeutics.
From Target to Therapeutic
A staged workflow that evolves peptides through directed selection, then conjugates winners to proven delivery platforms.
Target Selection
Define receptor targets and desired pharmacology profile
Peptide Evolution
AI-guided directed evolution across billions of sequence variants
Quality Gating
Multi-stage filters for binding, selectivity, and stability
Lead Optimization
Iterative cycles with assay feedback guiding evolution pressure
Scaffold Conjugation
Site-specific linkage to validated PK scaffolds
Modular Assembly
Multi-peptide conjugates for dual/tri-target therapeutics
Platform Capabilities
The infrastructure for building modular peptide therapeutics.
Peptide Evolution Engine
Explore sequence space at scale. Our AI searches billions of peptide variants, applying evolutionary pressure for multiple objectives simultaneously.
Multi-Target Design
Build molecules that hit 2-3 targets at once. Dual agonists, antagonist combinations, or mixed-mode therapeutics from modular components.
Fixed PK Platform
Validated scaffold proteins with known half-life profiles. Swap peptide payloads without reformulating pharmacokinetics.
Developability Screening
Every candidate assessed for aggregation, stability, and manufacturability. Identify liabilities before they become problems.
Modular PK/PD Architecture
Traditional biologics couple pharmacokinetics and pharmacodynamics into a single molecule. Change the target, and you reformulate everything.
Our platform separates these concerns. Validated scaffolds provide fixed, predictable PK profiles. Evolved peptides snap on as modular PD components. Mix and match to create:
- Dual-peptide agonists
- Tri-target conjugates
- Agonist/antagonist combinations
- Pathway-selective modulators